TNF and autoimmune disease: Better understanding the nuances of TNF superfamily receptor-ligand interactions will allow for more specific tailoring of therapeutics designed to block these interactions (such as when and how to use TNF-blocking antibodies in autoimmune disease) and the ability to exploit these interactions when enhanced immunity is desired (as in cancer immunotherapy).